We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature.
- Authors
Acharya, Ratna; Clapp, William; Upadhyay, Kiran
- Abstract
The inhibition of co-stimulation during T-cell activation has been shown to provide effective immunosuppression in kidney transplantation (KT). Hence, the conversion from calcineurin inhibitor (CNI) to belatacept is emerging as a potential alternate maintenance immunosuppressive therapy in those with transplant-associated thrombotic microangiopathy (TA-TMA) or in the prevention of TA-TMA. We present a 17-year-old male who presented with biopsy-proven CNI-associated TA-TMA immediately post-KT. The administration of eculizumab led to the reversal of TMA. Tacrolimus was converted to belatacept with excellent efficacy and safety during a short-term follow-up of one year. Further larger controlled studies are required to demonstrate the efficacy of this approach in children who present with early-onset TMA post-KT.
- Subjects
LITERATURE reviews; BELATACEPT; KIDNEY transplantation; IMMUNOSUPPRESSIVE agents; THROMBOTIC thrombocytopenic purpura; ECULIZUMAB
- Publication
Clinics & Practice, 2024, Vol 14, Issue 3, p882
- ISSN
2039-7283
- Publication type
Case Study
- DOI
10.3390/clinpract14030069